Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog(®) Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glu...

por Leohr, Jennifer, Dellva, Mary Anne, Carter, Kallin, LaBell, Elizabeth, Linnebjerg, Helle
Publicado 2021

Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects

por Linnebjerg, Helle, LaBell, Elizabeth Smith, Dellva, Mary Anne, Coutant, David E., Leohr, Jennifer
Publicado 2020

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Contro...

por Linnebjerg, Helle, Zhang, Qianyi, LaBell, Elizabeth, Dellva, Mary Anne, Coutant, David E., Hövelmann, Ulrike, Plum-Mörschel, Leona, Herbrand, Theresa, Leohr, Jennifer
Publicado 2020

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, cross...

por Heise, Tim, Linnebjerg, Helle, Coutant, David, LaBell, Elizabeth, Zijlstra, Eric, Kapitza, Christoph, Bue‐Valleskey, Juliana, Zhang, Qianyi, Dellva, Mary Anne, Leohr, Jennifer
Publicado 2020

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

por Leohr, Jennifer, Dellva, Mary Anne, Coutant, David E., LaBell, Elizabeth, Heise, Tim, Andersen, Grit, Zijlstra, Eric, Hermanski, Lidia, Nosek, Leszek, Linnebjerg, Helle
Publicado 2020

Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer’s Disease: A Phase I Clinical Trial

por Willis, Brian A., Lo, Albert C., Dage, Jeffrey L., Shcherbinin, Sergey, Chinchen, Louise, Andersen, Scott W., LaBell, Elizabeth S., Perahia, David G.S., Hauck, Paula M., Lowe, Stephen L.
Publicado 2023